CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Nandi, Bisweswar ^a,b   Pai, Christine ^a   Huang, Qin ^a,b   Prabhala, Rao H ^a,b,c   Munshi, Nikhil C ^a,b,c   Gold, Jason S ^a,b,d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; CCR6 PROTEIN, HUMAN; CCR6 PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; APC GENE; ARTICLE; CANCER CELL; CANCER CELL LINE; CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL TRANSFORMATION; COLON TUMOR; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; INTESTINAL NEOPLASMS; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CCL20; COLONIC NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENES, APC; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84901437996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097566     Document Type: Article

References (41)

1. Balkwill FR (2012) The chemokine system and cancer. J Pathol 226: 148-157.
2. Blanchet X, Langer M, Weber C, Koenen RR, von Hundelshausen P (2012) Touch of chemokines. Front Immunol 3: 175.
3. Kakinuma T, Hwang ST (2006) Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79: 639-651. (Pubitemid 44835596)
4. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, et al. (1997) Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 272: 14893-14898. (Pubitemid 27251760)
5. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204: 2803-2812. (Pubitemid 350179551)
6. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, et al. (2009) CC chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10: 514-523.
7. Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, et al. (2008) CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 181: 8391-8401.
8. Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129: 2175-2183.
9. Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, et al. (2004) Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 24: 74-85. (Pubitemid 38375798)
10. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, et al. (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A 107: 5540-5544.
11. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, et al. (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491: 254-258.
12. Baltgalvis KA, Berger FG, Pena MM, Davis JM, Muga SJ, et al. (2008) Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol 294: R393-401.
13. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, et al. (2006) Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 66: 57-61. (Pubitemid 43166009)
14. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, et al. (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71: 1263-1271.
15. Rakoff-Nahoum S, Medzhitov R (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127. (Pubitemid 47056471)
16. Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, et al. (2006) Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 27: 166-174.
17. Kirshberg S, Izhar U, Amir G, Demma J, Vernea F, et al. (2011) Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression. PLoS One 6: e24856.
18. Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, et al. (2008) Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 134: 1181-1189.
19. Frick VO, Rubie C, Kolsch K, Wagner M, Ghadjar P, et al. (2013) CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies. Scand J Immunol 78: 298-305.
20. Dellacasagrande J, Schreurs OJ, Hofgaard PO, Omholt H, Steinsvoll S, et al. (2003) Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J Immunol 57: 534-544. (Pubitemid 36734993)
21. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, et al. (2006) Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 24: 1910-1916. (Pubitemid 46646227)
22. Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN (2004) Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J 10: 374-380. (Pubitemid 44313545)
23. Brand S, Olszak T, Beigel F, Diebold J, Otte JM, et al. (2006) Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 97: 709-723.
24. Keates S, Han X, Kelly CP, Keates AC (2007) Macrophage-inflammatory protein-3alpha mediates epidermal growth factor receptor transactivation and ERK1/2 MAPK signaling in Caco-2 colonic epithelial cells via metalloproteinase-dependent release of amphiregulin. J Immunol 178: 8013-8021. (Pubitemid 46898072)
25. Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
26. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
27. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318-1321. (Pubitemid 16002234)
28. Beider K, Abraham M, Begin M, Wald H, Weiss ID, et al. (2009) Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One 4: e5125.
29. You S, Ohmori M, Pena MM, Nassri B, Quiton J, et al. (2006) Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int J Exp Pathol 87: 227-236. (Pubitemid 43781688)
30. Wang C, Kang SG, Lee J, Sun Z, Kim CH (2009) The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2: 173-183.
31. Lau SK, Chu PG, Weiss LM (2004) CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 122: 794-801. (Pubitemid 39434761)
32. Fenton JI, Birmingham JM (2010) Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol Carcinog 49: 700-709.
33. Iwata T, Tanaka K, Inoue Y, Toiyama Y, Hiro J, et al. (2012) Macrophage inflammatory protein-3 alpha (MIP-3a) Is a novel serum prognostic marker in patients with colorectal cancer. J Surg Oncol 107: 160-166.
34. Liu J, Zhang N, Li Q, Zhang W, Ke F, et al. (2011) Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 6: e19495.
35. Hausmann M, Bataille F, Spoettl T, Schreiter K, Falk W, et al. (2005) Physiological role of macrophage inflammatory protein-3 alpha induction during maturation of intestinal macrophages. J Immunol 175: 1389-1398. (Pubitemid 41023038)
36. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, et al. (2000) Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192: 705-718.
37. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, et al. (1997) CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 186: 837-844. (Pubitemid 27407345)
38. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237.
39. McClellan JL, Davis JM, Steiner JL, Enos RT, Jung SH, et al. (2012) Linking tumor associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am J Physiol Gastrointest Liver Physiol 303: G1087-1095.
40. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, et al. (2000) CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12: 495-503.
41. Varona R, Villares R, Carramolino L, Goya I, Zaballos A, et al. (2001) CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J Clin Invest 107: R37-45. (Pubitemid 32225363)